Moreover, previous studies have confirmed that macrophage CD36 promotes atherosclerosis (62, 63, 64, 65), and that CD36 deficiency reduces atherosclerotic lesion formation in ECs (66). This evidence concerns the gene CD36 and atherosclerosis.